Brief: Active Biotech Enters Into Manufacturing Deal With Famar Health Care Services

Active Biotech AB publ

04/02/2021 14:02

Feb 4 (Reuters) - Active Biotech AB (publ)  ACTI.ST :
    * REG-ACTIVE BIOTECH ENTERS INTO A MANUFACTURING AGREEMENT
WITH
FAMAR HEALTH CARE SERVICES FOR NEW FORMULATION OF LAQUINIMOD
    * TODAY ANNOUNCED IT HAS REACHED A MANUFACTURING AGREEMENT
WITH
FAMAR HEALTH CARE SERVICES MADRID SAU
    * FAMAR WILL DELIVER CLINICAL TRIAL MATERIAL OF NEWLY
DEVELOPED
EYE-DROP FORMULATION OF LAQUI-NIMOD.
    * PROJECT HAS BEEN INITIATED, AND ACTIVE BIOTECH IS AIMING
TO
START A CLINICAL SAFETY STUDY IN H2 2021
    * ACTIVE BIOTECH ALSO PLANS TO INITIATE A PROOF-OF-PRINCIPLE
STUDY
WITH ORAL LAQUINIMOD IN UVEITIS PATIENTS IN 2021.

Source text for Eikon:  ID:nGNE2KK4XP 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))